Team Behind Evrysdi Win 2 Prestigious ‘Drug Discovery’ Awards

Team Behind Evrysdi Win 2 Prestigious ‘Drug Discovery’ Awards

314056

Team Behind Evrysdi Win 2 Prestigious ‘Drug Discovery’ Awards

The team of researchers who discovered and developed Evrysdi (risdiplam) — the first at-home oral therapy for spinal muscular atrophy (SMA) — was selected as the winner of two prestigious treatment discovery awards. These are the Society for Medicines Research (SMR)’s 2021 Award for Drug Discovery and the British Pharmacological Society (BFS)’s 2022 Drug Discovery of the Year award. Both were established to recognize outstanding contributions, achievements, and inventions in the world of treatment discovery and development…

You must be logged in to read/download the full post.